دورية أكاديمية
Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN.
العنوان: | Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN. |
---|---|
المؤلفون: | Zavala K; UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America., Gottlieb CA; UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America., Teles RM; Division of Dermatology, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California, United States of America., Adams JS; UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America., Hewison M; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland., Modlin RL; Division of Dermatology, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California, United States of America., Liu PT; UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America.; Division of Dermatology, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California, United States of America. |
المصدر: | PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Oct 09; Vol. 12 (10), pp. e0006815. Date of Electronic Publication: 2018 Oct 09 (Print Publication: 2018). |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
اللغة: | English |
بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science |
مواضيع طبية MeSH: | Immune Evasion*, Immunologic Factors/*pharmacology , Interferon Type I/*metabolism , Macrophages/*immunology , Macrophages/*microbiology , Mycobacterium leprae/*physiology , Vitamin D/*pharmacology, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/biosynthesis ; Humans ; Immunity, Innate ; Mycobacterium leprae/immunology ; Up-Regulation |
مستخلص: | Following infection, virulent mycobacteria persist and grow within the macrophage, suggesting that the intrinsic activation of an innate antimicrobial response is subverted by the intracellular pathogen. For Mycobacterium leprae, the intracellular bacterium that causes leprosy, the addition of exogenous innate or adaptive immune ligands to the infected monocytes/macrophages was required to detect a vitamin D-dependent antimicrobial activity. We investigated whether there is an intrinsic immune response to M. leprae in macrophages that is inhibited by the pathogen. Upon infection of monocytes with M. leprae, there was no upregulation of CYP27B1 nor its enzymatic activity converting the inactive prohormone form of vitamin D (25-hydroxyvitamin D) to the bioactive form (1,25α-dihydroxyvitamin D). Given that M. leprae-induced type I interferon (IFN) inhibited monocyte activation, we blocked the type I IFN receptor (IFNAR), revealing the intrinsic capacity of monocytes to recognize M. leprae and upregulate CYP27B1. Consistent with these in vitro studies, an inverse relationship between expression of CYP27B1 vs. type I IFN downstream gene OAS1 was detected in leprosy patient lesions, leading us to study cytokine-derived macrophages (MΦ) to model cellular responses at the site of disease. Infection of IL-15-derived MΦ, similar to MΦ in lesions from the self-limited form of leprosy, with M. leprae did not inhibit induction of the vitamin D antimicrobial pathway. In contrast, infection of IL-10-derived MΦ, similar to MΦ in lesions from patients with the progressive form of leprosy, resulted in induction of type I IFN and suppression of the vitamin D directed pathway. Importantly, blockade of the type I IFN response in infected IL-10 MΦ decreased M. leprae viability. These results indicate that M. leprae evades the intrinsic capacity of human monocytes/MΦ to activate the vitamin D-mediated antimicrobial pathway via the induction of type I IFN. Competing Interests: The authors have declared that no competing interests exist. |
References: | Cell Host Microbe. 2009 Oct 22;6(4):343-53. (PMID: 19837374) Am J Respir Crit Care Med. 2007 Jul 15;176(2):208-13. (PMID: 17463418) J Exp Med. 1991 Nov 1;174(5):1031-8. (PMID: 1940785) Acta Med Indones. 2006 Jan-Mar;38(1):3-5. (PMID: 16479024) Sci Transl Med. 2011 Oct 12;3(104):104ra102. (PMID: 21998409) Science. 2006 Mar 24;311(5768):1770-3. (PMID: 16497887) J Cell Physiol. 2012 Sep;227(9):3258-66. (PMID: 22105341) BMC Infect Dis. 2013 Jan 19;13:22. (PMID: 23331510) Nat Med. 2012 Jan 29;18(2):267-73. (PMID: 22286305) Am J Respir Crit Care Med. 2009 May 1;179(9):843-50. (PMID: 19179490) Lancet. 1946 Jun 22;1(6408):919-22. (PMID: 20991437) PLoS Pathog. 2012;8(6):e1002769. (PMID: 22737072) Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11205-11210. (PMID: 28973928) Nat Med. 2005 Jun;11(6):653-60. (PMID: 15880118) Infect Immun. 2005 May;73(5):2744-50. (PMID: 15845477) Hum Immunol. 2010 Oct;71(10):992-8. (PMID: 20650301) New Microbes New Infect. 2015 Apr 16;6:35-9. (PMID: 26106480) Boll Chim Farm. 1998 May;137(5):157-64. (PMID: 9689902) FEMS Immunol Med Microbiol. 2006 Oct;48(1):91-8. (PMID: 16965356) Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22593-8. (PMID: 21149724) Bull World Health Organ. 1974;51(5):451-65. (PMID: 4549496) Cell Immunol. 2004 May;229(1):13-20. (PMID: 15331324) Infect Immun. 2002 Sep;70(9):5167-76. (PMID: 12183567) J Immunol. 2008 Nov 15;181(10):7115-20. (PMID: 18981132) J Infect Dis. 1999 Jan;179(1):187-91. (PMID: 9841838) Dermatologica. 1957 Oct;115(4):491-5. (PMID: 13490050) Virulence. 2017 Aug 18;8(6):848-858. (PMID: 27763806) Science. 2013 Mar 22;339(6126):1448-53. (PMID: 23449998) Nat Med. 2003 May;9(5):525-32. (PMID: 12692544) BMJ. 2011 Dec 20;343:d7505. (PMID: 22187324) Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. (PMID: 22949664) J Clin Invest. 2009 Jul;119(7):1910-20. (PMID: 19487810) FASEB J. 2006 Nov;20(13):2417-9. (PMID: 17023519) PLoS Pathog. 2010 Oct 21;6(10):e1001159. (PMID: 20975946) J Interferon Cytokine Res. 2012 Jan;32(1):27-33. (PMID: 21981546) Mol Cell Biol. 1993 Jan;13(1):588-99. (PMID: 7678054) Lancet. 2011 Jan 15;377(9761):242-50. (PMID: 21215445) Lepr Rev. 1962 Apr;33:119-28. (PMID: 14492126) J Exp Med. 2010 Sep 27;207(10):2053-63. (PMID: 20837696) |
معلومات مُعتمدة: | P50 AR063020 United States AR NIAMS NIH HHS; R01 AI022553 United States AI NIAID NIH HHS; R01 AR040312 United States AR NIAMS NIH HHS |
المشرفين على المادة: | 0 (Immunologic Factors) 0 (Interferon Type I) 1406-16-2 (Vitamin D) EC 1.14.15.18 (25-Hydroxyvitamin D3 1-alpha-Hydroxylase) |
تواريخ الأحداث: | Date Created: 20181010 Date Completed: 20190109 Latest Revision: 20240314 |
رمز التحديث: | 20240314 |
مُعرف محوري في PubMed: | PMC6177120 |
DOI: | 10.1371/journal.pntd.0006815 |
PMID: | 30300363 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1935-2735 |
---|---|
DOI: | 10.1371/journal.pntd.0006815 |